Key Insights

Highlights

Success Rate

83% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

5.6%

3 terminated out of 54 trials

Success Rate

83.3%

-3.2% vs benchmark

Late-Stage Pipeline

7%

4 trials in Phase 3/4

Results Transparency

13%

2 of 15 completed with results

Key Signals

2 with results83% success

Data Visualizations

Phase Distribution

35Total
Not Applicable (18)
Early P 1 (2)
P 1 (2)
P 2 (9)
P 3 (2)
P 4 (2)

Trial Status

Unknown19
Completed15
Recruiting8
Not Yet Recruiting4
Terminated3
Active Not Recruiting2

Trial Success Rate

83.3%

Benchmark: 86.5%

Based on 15 completed trials

Clinical Trials (54)

Showing 20 of 20 trials
NCT07561931Not ApplicableNot Yet RecruitingPrimary

Effects of High-frequency Left Dorsolateral Prefrontal rTMS on Heart-brain Coupling in Women With Recurrent Pregnancy Loss and Elevated BMI

NCT07325370Not ApplicableRecruitingPrimary

Cardiac Autonomic and Anxiety Regulation Via Closed-loop nEurofeedback in Recurrent Pregnancy Loss

NCT06182878Not ApplicableRecruitingPrimary

Tender Loving Care for Recurrent Pregnancy Loss

NCT06968026Not ApplicableRecruitingPrimary

High-Intensity, Low-Frequency Periodic rTMS Over the Right Dorsolateral Prefrontal Cortex on Cardiac Autonomic Regulation in Women With Recurrent Pregnancy Loss and Anxiety

NCT07542600Not ApplicableNot Yet Recruiting

Effect of Comprehensive Spa Rehabilitation on Female Infertility: A Clinical Study in Adult Women (Infertility-Spa)

NCT05444283RecruitingPrimary

Genomic Predictors of Recurrent Pregnancy Loss

NCT07265505Not ApplicableNot Yet Recruiting

Study of Endometrial Immune and Microbiological Modifications in Cases of Recurrent Implantation Failure and/or Recurrent Pregnancy Loss

NCT02572154Not ApplicableCompletedPrimary

Sperm DNA Fragmentation in Recurrent Pregnancy Loss

NCT05169541Recruiting

Association Between Plasma Level of Mannose Binding Lectin and Human Reproduction

NCT04701034Phase 2Completed

Intravenous Immunoglobulin and Prednisolone for RPL After ART.

NCT06652113Not ApplicableRecruitingPrimary

Effect of HCQ Combined With LT4 on LBR in Euthyroid Women With URPL and TPO-Ab

NCT06007560Not ApplicableActive Not RecruitingPrimary

Aerobe Cycling Training in Women With Unexplained Recurrent Pregnancy Loss

NCT03401918Phase 2CompletedPrimary

Assessing the Endometrial Environment in Recurrent Pregnancy Loss and Unexplained Infertility

NCT05989178RecruitingPrimary

Prospective Recurrent Pregnancy Loss Registry

NCT05725512Phase 4Recruiting

Prednisolone Administration in Patients With Unexplained REcurrent MIscarriages

NCT05186779Terminated

Maternal and Newborn Safety Profile of Progestogens in EARLY Pregnancy

NCT05073978Completed

B-vitamin Levels and Adverse Pregnancy Outcomes

NCT05802784Not ApplicableCompleted

Hysteroscopic Septoplasty by Different Modalities

NCT05656846Not ApplicableUnknownPrimary

Biweekly Follow-Up and At-Home Ultrasound Reduce Anxiety in Women With Recurrent Pregnancy Loss

NCT05342948CompletedPrimary

Association of HY-restricting HLA Class II Alleles, Sex of Firstborn Child, and Pregnancy Outcome in RPL Patients

Scroll to load more

Research Network

Activity Timeline